President Trump on Friday quietly signed into law a sweeping measure that will help ensure the Food and Drug Administration can continue to oversee drug and device approvals.
It’s a victory for the pharmaceutical industry, which, together with the FDA, fought to ensure the package would become law before existing agreements expire at the end of September. The industry will pay more than $1 billion toward the agency’s oversight efforts, per an agreement hammered out with lawmakers and the FDA. Both industry and the agency say the so-called user fees are critical to keeping the lights on at the FDA.
About the Author Reprints
So. Does this mean user fee biggest fee paid gets industries product pushed forward faster into commercial production?product